Prognostic Significance of Peritumoral Lymphatic Vassel Invasion in Breast Cancer.
- Author:
Geun Tong PARK
1
;
Min Gyun IM
;
Lee Su KIM
;
Song KIM
;
Chang Sig CHOI
;
Bong Hwa LEE
Author Information
1. Department of Surgery, College of Medicine, Hallym University, Seoul, Korea.
- Publication Type:Original Article ; Clinical Trial
- Keywords:
Breast cancer;
PLVI;
Prognostic factor
- MeSH:
Animals;
Breast Neoplasms*;
Breast*;
Disease-Free Survival;
Estrogens;
Humans;
Lymph Nodes;
Lymphatic Vessels;
Neoplasm Metastasis;
Progesterone;
Receptors, Progesterone;
Recurrence;
Survival Rate
- From:Journal of the Korean Cancer Association
1998;30(5):943-950
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The well-known prognostic factors for breast cancer, such as axillary lymph node status, do not always account for the exact outcome. The developinent of other accurate prognostic factors would help in assessing high risk for the disease recurrence and death. Recently, there are reports that peritumoral lymphatic vessel invasion is a good prognostic factor to solid tumors in animal studies and clinical trials. This study was performed to estimate the significance of peritumoral lymphatic vessel invasion (PLVI) as a prognostic factor in breast cancer. Also, PLVI was compared with established clinicopathological prognostic factors and hormone receptors. MATERIALS AND METHODS: A group of patient was selected from the Department of Surgery, College of Medicine, Hallym University, which consists of 43 out of 96 patients who received curative operation from 1985 to 1993. Peritumoral lymphatic vessel invasion by tumor cells on H&E stain was considered PLVI positive. We classified 43 breast-cancer patients into 32 with negative PLVI and ll with positive PLVL. We estimated the correlation between the PLVI and other established prognostic factors. We also calculated survivals based on PLVI. RESULTS: The 4-year disease-free survival rate was 61.8+/-8.7%, and the 4-year overall survival rate was 73.0+/-8.0%. The receptor status of estrogen and of progesterone had significant impacts on survival (ER: p=0.0001, PR: p=0.0001). Also, metastasis status of lymph node had significant impacts on overall survival (p=0.0148). We found a significant correlation between PLVI and tumor size (p=0.004), estrogen receptor (p=0.002), progesterone receptor (p=0.006), but could not find any significant corelation between PLVI and menopausal status, histologic grade, nuclear grade, lymph node metastasis. PLVI status was corelated with disease free survival rate (p=0.01) and overall survival rate (p=0.01). CONCLUSION: The determination of PLVI in breast cancer tissue may be useful as a prognostic factor, but it is necessary to investigate the PLVI in a large number of patients before this conclusion can be stated with certainty.
